Butanetap Therapy for Infection-Driven Neurological Damage
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Viral, bacterial, fungal, protozoan, or parasitic infections lead to overproduction of neurotoxic proteins, causing neurological damage and neurodegenerative diseases such as Alzheimer's, Parkinson's, and other conditions by increasing iron levels and triggering a toxic cascade in the brain.
Innovation Solution
Administering Butanetap or its analogues in therapeutically effective amounts to inhibit or treat neurological damage by maintaining heavy metal homeostasis and reducing neurotoxic protein production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If the brain produces amyloid beta to kill or trap microbes during infection, then the brain is protected from infection, but amyloid plaques build up triggering tau tangles and chronic inflammation leading to neurodegeneration
Solution Approach 1:
The patent converts the harmful overproduction of amyloid beta and tau proteins into a beneficial outcome by using small molecule compounds that specifically inhibit the toxic effects of these proteins while preserving their protective antimicrobial function. The compounds transform the pathological cascade into a controlled protective response.
Solution Approach 2:
The patent changes the concentration parameter of neurotoxic proteins by administering small molecule compounds that reduce amyloid beta and tau protein levels to therapeutic ranges, thereby preventing neurodegeneration while maintaining sufficient levels for microbial protection.
2Quantity of substance
If iron levels increase during brain infection, then microbial growth is supported, but neurotoxic protein translation is upregulated causing nerve cell death
Solution Approach 1:
The patent changes the iron metabolism parameter by administering compounds that regulate iron homeostasis in the brain, thereby preventing the upregulation of neurotoxic protein translation while maintaining sufficient iron for microbial defense mechanisms.
3Reliability
If neurons overproduce amyloid beta and tau proteins to trap microbes, then infection is contained, but the toxic cascade causes chronic inflammation and nerve cell death
Solution Approach 1:
The patent changes the concentration parameter of amyloid beta and tau proteins to therapeutic levels using small molecule compounds, thereby containing infections while preventing the toxic cascade that leads to chronic inflammation and nerve cell death.
Solution Approach 2:
The patent introduces small molecule compounds as intermediary substances that mediate between the protective immune response and the toxic effects, allowing the brain to contain infections without suffering neurodegenerative damage.
Data Source
AI summary
The invention relates to methods of inhibiting or treating neurological damage in a human who is infected by or at risk of infection by a virus, a bacterium, a fungus, a protozoan or a parasite that can cause neurological damage, comprising administering to a human a compound selected from the group consisting of Formula (I), Formula (II), Formula (III) or Formula (IV) or pharmaceutically acceptable salts thereof.